SynBioBeta Logo
Menu
SynBioBeta Logo
Menu

Live and in person January 25th - 27th 2022 @ the Oakland Marriott City Center

Our SAFETY FIRST conference protocols include: proof of vaccination, a Negative result COVID test taken within 72 hours of arrival, a comfortable mask and a big smile!  We can’t wait to see you!

Live and in person January 25th - 27th 2022 @ the Oakland Marriott City Center

"Because Being In The Same Room
Is Better Than Being On The Same Zoom!"

Our SAFETY FIRST conference protocols include: proof of vaccination, a Negative result COVID test taken within 72 hours of arrival, a comfortable mask and a big smile! We can’t wait to see you!

After two years of digital meetings, we’re bringing synthetic biology’s leading community of innovators, investors, engineers, entrepreneurs, scientists, thought leaders, policy makers and academics together to Build Back Better With Biology!

Early Bird Tickets and Marriott Reservations Now Open

Our world simply doesn’t look the same it did a year ago: The COVID-19 pandemic spawned so many new challenges and unearthed old ones. But synthetic biology is doing what it’s always done with large-scale challenges: Responding with innovative solutions.

In a year where collaborations, connections, and the exchange of ideas were all virtual, synthetic biology thrived. Yet, nothing quite compares to the electricity you feel in a room full of lead scientists, investors, and entrepreneurs, overcoming world-sized hurdles. It’s where we can be inspired, form lasting relationships, and build a better world.

The revolution that’s going on is impressive in its scope, touching so many familiar and unexpected industries. Gene-based therapeutics, life-science tools, sustainable food systems, and bio-based consumer materials are all gaining momentum and drawing greater interest and investment.

SynBioBeta 2021 is here to break it down for you and guide you through the electricity and the excitement, to the discussions, networking events, and meetings that are right for your interests and goals.

Here's what we've got planned...

Synthetic Biology is taking on the world’s biggest problems and winning!

We look forward to celebrating the amazing progress our community has made through the pandemic and vision casting for the very bright future that will be Built with Biology! The conference is designed to provide powerful business opportunities for those currently building with biology and serve as a field trip to the future for those still defining their bio-strategy.

What to expect

  • 3 days of in-person networking

  • Interact with new investors

  • Hands-on product demos

  • Industry trend updates

  • Amazing speakers & breakout sessions

  • Industry centric mixers & meet and greets

Add our event to your calendar

Don't worry - we've got you covered. See updated COVID refund policy.

We're Building Back with Biology - and There's a Lot to Build

Innovative Response

Our world simply doesn’t look the same it did a year ago: The COVID-19 pandemic spawned so many new challenges and unearthed old ones. But synthetic biology is doing what it’s always done with large-scale challenges: Responding with innovative solutions.

Advancing Industries

The revolution that’s going on is impressive in its scope, touching so many familiar and unexpected industries. Gene-based therapeutics, life science tools, sustainable food systems, and bio-based consumer materials are all gaining momentum and drawing greater interest and investment.

Coming Together

In a year where collaborations, connections, and the exchange of ideas were all virtual, synthetic biology thrived. Yet, nothing quite compares to the electricity you feel in a room full of lead scientists, investors, and entrepreneurs, overcoming world-sized hurdles. It’s where we can be inspired, form lasting relationships, and build a better world.

SynBioBeta 2021 is here to break it down for you and guide you through the electricity and the excitement, to the discussions, networking events, and meetings that are right for your interests and goals.

Strategic networking is critical to long term success, so we’ve organized six Synthetic Biology tracks that can be personalized in a way that allow you to hear from and meet the right people for your specific needs.

Next-Gen Medicine

Seeking partnerships in this new era of biopharma disruption and discovery? Follow our Next-Gen Medicine Track to connect with the leaders and trailblazers transforming the world of therapeutics.

Food of the Future

Synthetic biology is transforming our food systems. Follow this track and you’ll learn the latest food & ag technologies, the potential for cross-disciplinary partnerships, and the emerging opportunities in revolutionizing global food production supply chains.

Entrepreneurship

Are you ready to take your innovation out of the lab and into the hands of consumers? Follow our Entrepreneur Track to hear from seasoned experts about every step of the process.

Neurotech

Can we apply synthetic biology principles to the human brain? This track will guide attendees through the promises, challenges, and ethical questions of neurotech. It’s a brave new world and this is an exciting new space so be sure to check it out.

Advanced Sustainability

Biomanufacturing is changing how traditional chemicals and materials are being made. Throughout this track, we’ll cover the potential of bio-based materials, the opportunities and partnerships in the space, and how to scale these materials effectively to compete and disrupt petrochemical-based materials.

Tools and Technologies

Bioengineers are only as good as their tools. Join this track to hear how the latest bioengineering tools are reshaping the agriculture and biopharma industry. You'll get a chance to explore the latest platforms, full-stack technologies, robotic advances, and everything you need to take your business to the next level of innovation.

You’re free to mix-and-match sessions from any of the tracks and will have access to view sessions you miss, post conference, via the SynBioBeta app.

Interact, Engage, and Connect With Other Synthetic Biology Pioneers

At SynBioBeta 2021, there are so many different ways to tap into the synthetic biology community and find the innovators, entrepreneurs, and investors who can help you with your career, science, or business.

1:1 Networking

Grab a private room to meet 1-on-1 with new leads

Social Activities

Take a break from the sessions, recharge, and find a new connection throughout the venue

Social Lunch

Share our complimentary lunch with like-minded people in the industry

Explore Innovation

Roam the exhibit hall to see the latest groundbreaking technologies and the people that made them a reality

Exclusive Events

Join our daily, exclusive networking events

Connect with the Community

After a difficult year apart, take time to connect with old friends - and make some new ones, too!

Explore Synthetic Biology

Interact, Engage, and Connect With Other Synthetic Biology Pioneers

At SynBioBeta 2021, there are so many different ways to tap into the synthetic biology community and find the innovators, entrepreneurs, and investors who can help you with your career, science, or business.

Here's how you can take advantage of our unmatched networking opportunities

1:1 Networking

Grab a private room to meet 1-on-1 with new leads

Social Activities

Take a break from the sessions, recharge, and find a new connection throughout the venue

Social Lunch

Share our complimentary lunch with like-minded people in the industry

Explore Innovation

Roam the exhibit hall to see the latest groundbreaking technologies and the people that made them a reality

Exclusive Events

Join our daily, exclusive networking events

Connect with the Community

Join our daily, exclusive networking events

Value of Attending SynBioBeta 2020

New Contacts Made
0
Meetings
0
Attendees
0

Meet Some of Our 2022 Speakers

An incredible spectrum of innovators, thought leaders, and industry experts

Cathie Wood

Founder & CEO
Ark Invest

Steve Jurvetson

Founder & Managing Director
Future Ventures

Pat Brown

Founder & CEO
Impossible Foods

Jason Kelly

Founder & CEO
Ginkgo Bioworks

George Church

Professor
Harvard & MIT

Emily Leproust

CEO
Twist Bioscience

Eric Hobbs

CEO
Berkeley Lights

Lisa Dyson

CEO
Air Protein

Sri Kosaraju

CEO
Inscripta

Drew Endy

Associate Professor of Bioengineering
Stanford University

Jake Glanville

CEO & President
Centivax

Emily Chang

Anchor & Executive Producer
Bloomberg TV

Christine Gould

CEO
Thought For Food

Esther Dyson

Executive Founder
Way to Wellville

James Diggans

Head of Biosecurity
Twist Bioscience

Michael Leonard

CTO
Motif Foodworks

Nicole Richards

CEO
Allonnia

Keith Wood

CEO
Light Bio

Raymond R. Miller

Senior Global Product Manager
GenScript USA

Jeff Ubersax

CEO
Demetrix

Sonja Eliason

Sr. Manager, Strategy
Eagle Genomics

Kevin Holden

Head of Science
Synthego

Martin Moore

CEO
Meissa Vaccines

Mathew Miller

Senior Scientist, Molecular Engineering
Codexis

Bill Efcavitch

Chief Scientific Officer
Molecular Assemblies

Milana Trounce

Director of BioSecurity / Founding Chair of BioSecurity
Stanford / American College of Emergency Physicians

Amy Trejo

Director, R&D - Responsible Materials Innovation
Procter & Gamble Company

Taryn Southern

Emerging Tech Storyteller / Creative Director
Blackrock Neurotech (Creative Director) & Far Future Media (Founder)

Karyn Riegel

Dep. Director, Brand/Community Engagement
Leaps by Bayer

Ezhil Subbian

CEO
String Bio

John Cesarik

Head of Process Engineering
Insitro

Irene Song

Global Product Manager
Genscript USA

Mark Kotter

Founder & CEO
bit.Bio

Raj Judge

Senior Partner
Wilson Sonsini Goodrish & Rosati

Negin Mokhtari

Senior Associate
Genoa Ventures

Thomas Weingarten

PhD, Computational Biology
Google

Ernesto Simon

VP, Flavors & Fragrances
Conagen

Katherine Oglesby

Sr. Vice President & Head of Sensegen
Blue California

Nishan Degnarian

Special Advisor
World Economic Forum

Laura Katz

Founder & CEO
Helaina

Tim Cloutier

Senior VP, Commercial Operations
Codex DNA

Abril Estrada

Co-founder & Chief Product Officer
Wild Earth

Saran Dayal

VP, Research
Allonnia

Eben Bayer

CEO
Atlast Food Co.

Ryan Morhard

Director, Policy and Partnerships
Ginkgo Bioworks

Yasunori (Yas) Aizawa

Co-founder & CEO
Logomix Inc

Joel Makower

Chairman & Co-founder
GreenBiz Group

Patrick Boyle

Head of Codebase
Ginkgo Bioworks

Jaime Yassif

Senior Fellow
NTI | bio

Jason Pontin

Partner
DCVC

Rob Carlson

Managing Director
Bioeconomy Capital

Megan Palmer

Executive Director, Bio Policy & Leadership Initiatives
Stanford University

Karl Schmieder

CEO
Messaging Lab

Jojo Platt

President
Platt & Associates

Trevor Martin

CEO
Mammoth Biosciences

Renee Wegrzyn

Vice President of Business Development
Ginkgo Bioworks

Troy Lionberger

Associate Director, Technology Development
Berkeley Lights

Tal Zeltzer

Co-founder & CTO
Phytolon

Steve Hughes

Director of New Platform Development
GenScript

Karl Handelsman

Founder
Codon Capital

Zachary Sun

Co-founder & CEO
Tierra Biosciences

Moji Karimi

Co-founder & CEO
Cemvita Factory

Kimi Sato

CEO
bitBiome, Inc.

Ben Chiarelli

Founder & CEO
Cellibre

Anat Binur

Co-founder & CEO
Ukko Inc.

Amanda Pustilnik

Professor of Law
Center for Law, Brain & Behavior at MGH

Fiona Mischel

Editor in Chief
SynBioBeta

Nasir Bashiruddin

CTO
OriCiro Genomics, Inc.

John Melo

CEO & President
Amyris

Lloyd Kunimoto

CEO
Amfora

Marilene Pavan

Scientist
Lanzatech Inc.

Renee Ryan

CEO
Cala Health

Julia Moore

Managing Partner
Breakout Ventures

John Cumbers

Founder
SynBioBeta

J. Casey Lippmeier

VP of Innovation
Conagen Inc.

Nabiha Saklayen

Co-founder & CEO
Cellino

Mikael Eliasson

Global Head Innovation, Neuroscience
Genentech/Roche

Eric Abbate

Director of Analytical Biochemistry
Inscripta Inc.

Jacob Robinson

Associate Professor
Rice University

Kathryn Beabout

Research Scientist, Synthetic Biology
Air Force Research Laboratory

Omri Amirav Drory

General Partner
NFX Fund

Dietrich A Stephan

CEO & Chairman
NeuBase Therapeutics, Inc.

Howard Hutton

Research Fellow
The Procter & Gamble Company

Libby Schaaf

Mayor
City of Oakland

Frank Tate

CEO
SynBioBeta

Thomas Ybert

Co-founder & CEO
DNA Script

Jaleh Daie

Chairman, AgFoodHealthSpan
Band of Angels

Massimo Portincaso

Executive Chairman/Chairman
Officinae Bio/Hello Tomorrow

Ursheet Parikh

Partner
Mayfield Fund

Nandini Krishnamurthy

VP, Microbial Business Area
Inscripta

Nikhita Singh

Co-founder & CPO
Artificial Inc

Todd Nelson

CEO
Codex DNA

Terri Shieh-Newton

Member
Mintz

Arvind Gupta

Partner
Mayfield

Linda Elkins

Head of Gore Innovation Center
W. L. Gore & Associates

Natalie Kuldell

Founder & Executive Director
BioBuilder Educational Foundation

Daniel Rines

Senior Director, R&D Strategy
Strateos

Seiji Hirasaki

CEO
OriCiro Genomics

Charles Dimmler

Co-founder & CEO
Checkerspot

Matt Angle

Founder & CEO
Paradromics

Brian Pepin

Founder & CEO
Rune Labs

Tom Treynor

Founder & CEO
R2DIO, Inc

Aaron Sato

CSO
Twist Bioscience

Karim Engelmark Kassimjee

Co-founder & CEO
EnginZyme

Vincent Noireaux

Professor
University of Minnesota

Amy Kruse

Partner
Prime Movers Lab

Weston Kightlinger

Co-founder & CTO
SwiftScale Biologics

Magi Richani

Founder & CEO
Nobell Foods

Konstantinos Alataris

President & CEO
Nesos

Tycho Peterson

Managing Director | Equity Research – Life Science Tools & Diagnostics
J.P. Morgan

Tracy Kambara

Head of Molecular Biology
CATALOG

Tim Lu

Co-Founder & CEO
Senti Biosciences

Rahul Sarugaser

Managing Director
Raymond James Financial

Kristen Tran

Head of Automation
Ginkgo Bioworks

Derek Norman

VP of Venture Investments
Leaps by Bayer

Richard Ellson

CTO & Director of Research
Beckman Coulter Life Sciences

Steve McCloskey

Founder & CEO
Nanome Inc.

Marcus Gerhardt

Co-founder & CEO
Blackrock Neurotech

Stephanie Michelsen

Co-founder & CEO
Jellatech

Avery Bedows

Founder
The Substrate Group

Niya Gupta

Co-founder & CEO
Fork & Goode

Sunil Chandran

SVP & Head of R&D
Amyris

Ginger Dosier

CEO
Biomason

Carlton Fleming

Partner
Sidley Austin LLP

Ray Chen

President of Life Science Group
GenScript

Robert Leachman

Professor
University of California, Berkeley

Possu Huang

Assistant Professor
Stanford University

Timothy Stiles

Creator, Lead Developer of Poly
(Poly)merase

Oshiorenoya Agabi

CEO
Koniku Inc

Anthony Finbow

CEO
Eagle Genomics

Ganesh Kishore

Managing Partner
Spruce Capital Partners

Khalid Alam

Founder & CEO
Stemloop, Inc.

Erika Ross

Director, R&D
Abbott Neuromodulation

Pavle Jeremić

Founder & CEO
Aether Biomachines

Robert McBride

Co-founder & CEO
Felix Biotechnology, Inc.

Sam Sternberg

Associate Professor
Columbia University

Our three days together will include more than 1,300 industry peers and investors, 100 live sessions, 60 expo booths, 6 networking lounges for in-person meetings and our first annual Race Against the Clock Welcome Party for students and startups.

Tuesday January 25th, 10:00am - 6:00pm

Sessions Include: Pass the Burger, Hold the Cow: The Future of Food is Here

Kick off SynBioBeta 2021 with a round of inspiring sessions featuring some of the biggest investors, policy makers, engineers, Fortune 500 companies, synthetic biology CEOs, and global thought leaders. The afternoon will feature leaders in neuro-tech sharing how breakthrough technologies are transforming neuro-therapeutics and addressing the ethical challenges of this growing industry.

Wednesday January 26th, 10:00am - 6:00pm

Sessions Include: How the Biggest Global Brands are Betting Big on Biology

Synthetic biology aims to transform everything we touch. Discover what opportunities are being unlocked by novel food technologies, multidisciplinary techniques, and the changing consumer landscape. There will be key discussions on how the last year has reshaped the biopharma industry and what comes next for advanced diagnostics and therapeutics, including how the world of healthcare has been forever transformed.

Thursday January 27th, 10:00am - 6:00pm

Sessions Include: How to Red Team Your DNA Platform

Learn what it takes to bring your innovation to market, what tools are now available, and how you can grow your company with new opportunities and strategic partnerships. The afternoon will feature our 1st annual Race Against the Clock Welcome Party for students and startups, as well as our Field Trip to the Future Demo Day for the Press.

No matter what sessions you attend, you will never be short of opportunities to engage, network, and connect face-to-face in one of our networking lounges, meeting rooms, breakout sessions, or industry lunches. We can’t wait to be back in the same room!

Deploy faster

Strategic networking is critical to long-term success, so we’ve organized six customizable synthetic biology tracks to enable you to hear from and meet all the right people for your specific needs.

You’re free to mix-and-match sessions from any of the tracks and will have access to view sessions you miss, post conference, via the SynBioBeta app.

Next-Gen Medicine

Food of the Future

Startups & Students

Neurotech

Advanced Sustainability

Tools and Technologies

Meet The Sponsors You Can Connect With At SynBioBeta

SynBioBeta would not be possible without our amazing sponsors & exhibitors! Find some of them here in alphabetical order.


Want to showcase your company?

At SynBioBeta we have plenty of opportunities for any size company to be showcased. Explore how we can help you reach your goals by connecting with our fantastic strategy team.

Contact us for opportunities

Impact for Sponsors & Exhibitors from the Last SynBioBeta

Sponsor Views
0
Exhibitor Connections
0

See What Past Attendees Are Saying About SynBioBeta Events

  • SynBioBeta has the best mix of speakers - you can expect to see anyone ranging from a startup to a fortune 500 company

    Massimo Portincaso
    Managing Director & Partner, BCG
  • Over the past year, the COVID-19 has resulted in the cancelation of events across industries. That hasn't been the case with SynBioBeta. In fact, their virtual events have helped me imagine what networking can look like. At a time when we're more isolated, SynBioBeta's platform for making human connections remains a bright spot

    Karl Schmieder
    CEO, MessagingLab
  • SynBioBeta offers a uniquely creative and thought-provoking meeting place for synthetic biology innovators, investors, and thought leaders to collaborate in solving our world’s biggest problem through biology. These events are unparalleled in our industry

    Karyn Riegel
    Deputy Director Brand & Community Engagement, Leaps by Bayer
  • SynBioBeta is one of the most exciting places on earth for synthetic biology entrepreneurship aficionados like myself

    Seth Bannon
    Founding Partner, Fifty Years

Meet Your Hosts for SynBioBeta

John began his career at NASA Ames, in the heart of Silicon Valley, where he sought answers to how humans could live to visit the far reaches of our universe. Now at SynBioBeta, he works to empower a community of bio-entrepreneurs, companies, investors, researchers, visionaries, and thought leaders to bring projects to life. Through his leadership at SynBioBeta, John aims to facilitate the critical scientific and entrepreneurial collaborations that will shape the future of humanity.

John Cumbers
Founder, SynBioBeta

Fiona Mischel is the Director of International Outreach at SynBioBeta. She is currently leading SynBioBeta’s international expansion from London and is dedicated to breaking down industry silos and connecting the global bioeconomy. Fiona was previously the Editor-in-Chief of SynBioBeta and she remains keen to tell the stories of building a better future with biology.

Her other favorite stories include Lord of the Rings, Battlestar Galactica, and, Eurovision Song Contest: Fire Saga. She can’t wait for all sushi to be cell-based and her houseplants to be bioluminescent.

Fiona Mischel
Director of International Outreach, SynBioBeta

In his own words, Frank has, “Spent the last 40 years pursuing two goals: making ugly stuff pretty and helping high capacity people do what they do better.” More formally, Frank’s experience includes working for MTV's live specials team, owning an Indie record company, managing multiple authors and speakers, designing buildings and houses, starting software ventures, and (on a dare) creating the Bay Area’s biggest family entertainment center which hosted over 21,000 birthday parties in 9 years.

Frank loves laughing, 80’s music, Justin Bieber, Ted Lasso and is honored to help evangelize the Built with Biology message.

Frank Tate
CEO, SynBioBeta

It's All Happening on the SynBioBeta Swapcard App

The SynBioBeta app on a smartphone
Get access on Swapcard buttonGet it on Google PlayDownload on the App Store

Strategic networking is critical to long term success, so we’ve organized six Synthetic Biology tracks that can be personalized in a way that allow you to hear from and meet the right people for your specific needs.

Next-Gen Medicine

Seeking partnerships in this new era of biopharma disruption and discovery? Follow our Next-Gen Medicine Track to connect with the leaders and trailblazers transforming the world of therapeutics.

Food of the Future

Synthetic biology is transforming our food systems. Follow this track and you’ll learn the latest food & ag technologies, the potential for cross-disciplinary partnerships, and the emerging opportunities in revolutionizing global food production supply chains.

Entrepreneur

Are you ready to take your innovation out of the lab and into the hands of consumers? Follow our Entrepreneur Track to hear from seasoned experts about every step of the process.

Neurotech

Can we apply synthetic biology principles to the human brain? This track will guide attendees through the promises, challenges, and ethical questions of neurotech. It’s a brave new world and this is an exciting new space so be sure to check it out.

Advanced Sustainability

Biomanufacturing is changing how traditional chemicals and materials are being made. Throughout this track, we’ll cover the potential of bio-based materials, the opportunities and partnerships in the space, and how to scale these materials effectively to compete and disrupt petrochemical-based materials.

Tools and Technologies

Bioengineers are only as good as their tools. Join this track to hear how the latest bioengineering tools are reshaping the agriculture and biopharma industry. You'll get a chance to explore the latest platforms, full-stack technologies, robotic advances, and everything you need to take your business to the next level of innovation.

You’re free to mix-and-match sessions from any of the tracks and will have access to view sessions you miss, post conference, via the SynBioBeta app.

cross